Loading...
•
Sep 30, 2024
Teladoc Q3 2024 Earnings Report
Teladoc Health's Q3 2024 results reflected a commitment to execution, with initiatives to strengthen the business and unlock future growth.
Key Takeaways
Teladoc Health reported Q3 2024 revenue of $640.5 million, a 3% decrease year-over-year. Net loss was $33.3 million, or $0.19 per share. The Integrated Care segment saw revenue increase by 2%, while the BetterHelp segment experienced a 10% decrease.
Revenue decreased by 3% year-over-year to $640.5 million.
Net loss was $33.3 million, or $0.19 per share.
Adjusted EBITDA decreased by 6% year-over-year to $83.3 million.
Integrated Care segment revenue increased by 2%, while BetterHelp segment revenue decreased by 10%.
Revenue by Segment
Revenue by Geographic Location
Forward Guidance
Teladoc Health provided financial outlook for the Integrated Care segment for Q4 2024.
Positive Outlook
- Expects Integrated Care revenue growth percentage (year-over-year) of 0% - 2.5%.
- Expects Integrated Care adjusted EBITDA margin of 12.25% - 13.75%.
- Anticipates U.S. Integrated Care Members to be 93.5 - 94.5 million.
- Expects Integrated Care revenue growth percentage for full year 2024 in the low to mid-single digits.
- Anticipates Integrated Care adjusted EBITDA margin for full year 2024 to be 14.9% - 15.3%.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...